AstraZeneca seeks U.S. emergency approval for COVID-19 prevention drug
Global News
AstraZeneca said its late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.
AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.
In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.
The antibody therapy called AZD7442 could protect people who do not have a strong enough immune response to COVID-19 vaccines or to supplement a vaccination course for those, such as military personnel, who need to booster their protection further, AstraZeneca has said.
While vaccines rely on an intact immune system to develop targeted antibodies and infection-fighting cells, AZD7442 contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.
A U.S. authorization for AZD7442 – based on two antibodies discovered by Vanderbilt University Medical Center in the United States – could be a major win for AstraZeneca, whose widely used COVID-19 vaccine has yet to be approved by U.S. authorities.
Talks regarding supply agreements for AZD7442 are ongoing with the United States and other governments, AstraZeneca said.
COVID-19 therapies based on the same class of monoclonal antibodies are being developed by rivals Regeneron, Eli Lilly and GlaxoSmithKline with partner Vir, competing for a role in COVID-19 treatment and prevention. But Astra’s filing has cemented its lead in prevention.
That contrasts with delays in Astra’s quest for approval for its COVID-19 vaccine Vaxzevria in the United States, where the vast majority of those willing to get immunized have received shots from the Pfizer-BioNTech alliance, Moderna or Johnson & Johnson.
This year, the toy drive will support nearly 200 Ukrainian children in the Central Okanagan.
The choice of Trump's former acting attorney general Matt Whitaker is an unusual one, given his background in law enforcement and not in foreign policy or diplomacy.
Israel has continued to pound Hezbollah throughout the cease-fire attempts, and rockets have continued to rain down on northern Israel.
The precautionary step came after Russian officials promised a response to President Joe Biden’s decision to let Ukraine strike targets on Russian soil with U.S.-made missiles.
U.S. Secretary of State Antony Blinken recognized González in a post on X in which he also demanded “respect for the will” of Venezuelan voters.
Officials were worried the hamsters would target the plane's electrical wiring system.
Marius Borg Høiby is facing yet another charge after a slew of accusations in recent months.
Uranium enriched at 60 per cent purity is just a short, technical step away from weapons-grade levels of 90 per cent, according to the UN report.
The alleged developments marked a worrying new escalation in the conflict that has repeatedly ratcheted up international tensions.
The foreign ministries of Finland and Germany said that the damage raised suspicion of sabotage.
Putin’s endorsement of the new nuclear deterrent policy comes on the 1,000th day after he sent troops into Ukraine, on Feb. 24, 2022.